发明名称 METHOD OF PREDICTING SURVIVAL POTENTIAL OF PATIENTS WITH MALIGNANT GLIOMAS
摘要 FIELD: medicine. ^ SUBSTANCE: in patient's urine content of 6-sulfatoximelatonin is determined. If determined content of 6-sulfatoximelatonin after operation before complex treatment equals 292.7 nmol/ml survival to 2.30.5 months is predicted, if 22.4 nmol/ml is determined, survival for more than 12 months is predicted. If after chemical therapy determined content of 6-sulfatoximelatonin equals 268.2 nmll/ml, predicted survival time equals to 2.10.6 months, if content is 32.8 nmol/ml - more than 12 months. If after a month after treatment determined content of 6-sulfatoximelatonin equals 479.3 nmol/ml predicted is survival for 1.20.5 months, in case of 37.4 nmol/ml - survival for more than 12 months. ^ EFFECT: increased accuracy of predicting survival of patients with low-differentiated glial brain tumours. ^ 7 dwg, 1 tbl, 3 ex
申请公布号 RU2439577(C2) 申请公布日期 2012.01.10
申请号 RU20100107100 申请日期 2010.02.25
申请人 FEDERAL'NOE GOSUDARSTVENNOE UCHREZHDENIE "ROSTOVSKIJ NAUCHNO-ISSLEDOVATEL'SKIJ ONKOLOGICHESKIJ INSTITUT FEDERAL'NOGO AGENTSTVA PO VYSOKOTEKHNOLOGICHNOJ MEDITSINSKOJ POMOSHCHI";SIDORENKO JURIJ SERGEEVICH;FRANTSIJANTS ELENA MIKHAJLOVNA;BALJAZIN IGOR' VIKTOROVICH;ATMACHIDI DMITRIJ PANAETOVICH;KOMAROVA EKATERINA FEDOROVNA;POGORELOVA JULIJA ALEKSANDROVNA 发明人 SIDORENKO JURIJ SERGEEVICH;FRANTSIJANTS ELENA MIKHAJLOVNA;BALJAZIN IGOR' VIKTOROVICH;ATMACHIDI DMITRIJ PANAETOVICH;KOMAROVA EKATERINA FEDOROVNA;POGORELOVA JULIJA ALEKSANDROVNA
分类号 G01N33/74 主分类号 G01N33/74
代理机构 代理人
主权项
地址